539206 — Genomic Valley Biotech Balance Sheet
0.000.00%
Last trade - 00:00- IN₹189.38m
- IN₹185.20m
- IN₹1.65m
Annual balance sheet for Genomic Valley Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.378 | 0.115 | 0.027 | 0.413 | 0.061 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.03 | 0.649 | 0 | 22.2 | 25.3 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4.04 | 1.64 | 11.4 | 25.8 | 29.1 |
| Net Property, Plant And Equipment | 49.4 | 63.3 | 17.5 | 0.032 | 0.021 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 80.1 | 76.2 | 38 | 44.2 | 43.3 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.68 | 8.71 | 2.14 | 8.93 | 7.91 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 29.6 | 31.3 | 9.19 | 8.94 | 7.92 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 50.5 | 44.9 | 28.8 | 35.3 | 35.4 |
| Total Liabilities & Shareholders' Equity | 80.1 | 76.2 | 38 | 44.2 | 43.3 |
| Total Common Shares Outstanding |